Script Growth Especially At Mail Continue To Slow

Based on IMS data, prescription growth continues to slow especially at mail order where it’s negative.  Interestingly, in a report by Barclay’s Capital, they estimate that Caremark will grow mail by 10% next year, Express Scripts will lose mail scripts by about 0.5%, and Medco will only grow by 0.8%.

Medco is easy to understand since they are currently the market leader in terms of mail order penetration.  The Express Scripts number requires some additional analysis.  Is it due to client loss?  Is mail just not growing?  The Caremark growth is meaningful.

ims-script-growth-barclaysims-mail-growth-barclays

Advertisements

Trackbacks/Pingbacks

  1. Mail Order Prescriptions Dropped 9.2% – WOW! | Enabling Healthy Decisions - June 17, 2014

    […] 2012 to 2013 (excluding Medicare) dropped 9.2% while retail prescriptions jumped 2.7%.  (This is not new news, but this is a big […]

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: